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Background: The aim of this study was to estimate the incidence, main causes, and risk factors of iatrogenic disease occurring in a
department of internal medicine.
Methods: Over a 1-year period, physicians systematically filled out a 2-page questionnaire for all patients admitted to the ward. A database
was created and the data were statistically analyzed. Patients undergoing immunosuppressive, chemo-, or radiation therapy were excluded.
Missing data were completed by reviewing the patients' charts. The patients were then divided into two groups: those with and those without
iatrogenic disease. The groups were compared using several parameters including gender, age, social features, days of hospitalization,
associated illness, functional status, medical impression, prognosis, associated renal or liver function impairment, drugs taken daily, and
outcome. In the group with iatrogenic disease, the type, severity, and predictability were also analyzed.
Results: Of the 879 patients admitted to the ward, 445 completed questionnaires and were included in the study. A total of 102 patients
(22.9%) developed 121 iatrogenic events. Forty-four patients (43.1%) were admitted for iatrogenic illness, 10 (9.8%) developed life-
threatening events, and in 3 (6.8%) it was the cause of death. Fifty-eight patients (56.8%) registered 77 episodes of iatrogenic disease during
their hospital stay, 20 (19.6%) developed life-threatening events, and 9 (11.7%) died, 4 (5.2%) of an iatrogenic cause (nosocomial infections).
Significant differences were found in 20 out of 26 parameters studied ( pb0.005 for all cases; 95% confidence interval). Eighteen percent of
all iatrogenic disease was severe, 61.9% predictable, 54.5% avoidable, and 59% drug-related, 80% of which was due to side effects or
adverse reactions. Infection and metabolic and electrolyte disorders were the most frequent effects.
Conclusions: It is possible to identify risk factors for iatrogenic events. Chronically ill elderly inpatients are the main target of iatrogenic
events.
© 2007 European Federation of Internal Medicine. Published by Elsevier B.V. All rights reserved.Keywords: Iatrogenic disease; Incidence; Internal medicine department; Prospective study; Risk factors⁎ Corresponding author. Tel.: +351 239400426.
E-mail addresses: amadeira@huc.min-saude.pt,
madeirasofia@gmail.com (S. Madeira).
1 R. Padre Américo, 42, 3° dto. 3000-313 Coimbra, Portugal. Tel.: +351
912248422.
0953-6205/$ - see front matter © 2007 European Federation of Internal Medicine
doi:10.1016/j.ejim.2006.12.0091. Introduction
From the Greek words iatrós, meaning “medical”, and
geneá, meaning “origin”, iatrogenic means the occurrence
of negative effects caused by a medical procedure. It is
frequently thought that iatrogenic means “error” or
“neglect”, but iatrogenic effects and medical errors are
opposite terms, not synonymous ones [1]. An error is a. Published by Elsevier B.V. All rights reserved.
Table 1
Types of adverse drug reactions (ADRs)
Averse drug
reaction
— An event that is noxious and unintended and occurs
with doses used in humans for prophylaxis, diagnosis,
therapy, or modification of physiological functions
(intentional or deliberate overdose or drug abuse are
excluded)
Type A reaction — Caused by known toxicity of the drug, dose-related
and pharmacological effect (like bleeding caused by
warfarin)
— Potentially preventable
Type B reaction — Idiosyncratic or allergic in nature
— Reactions that usually occur from the initial use of a
drug in a patient are not predictable and, therefore, not
preventable
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concept of medical attitude, whereas an iatrogenic effect is
the consequence of an accurate action based on a correct
indication and adequate criteria and can be predicted by the
physician [1]. When, in trying to heal, relieve, or treat a
patient, the physician (like any other health care worker)
generates psychological, functional, or organic illness that
takes the from of pain, disease, or disturbance, he is being
iatrogenic. The diagnosis may be difficult, delayed, or
initially missed as iatrogenic illness can be generated
directly from the doctor–patient relationship or by means of
agents used in the diagnostic search, or as a consequence of
a therapeutic, instrumental (technical), or drug-related
measure [1,2].
Iatrogenic disease is a serious problem with a great social
impact. It occurs very frequently, is expensive [3–8,12–16],
and is potentially responsible for high morbidity and
mortality [5,6,8,12–14,17,18]. In the U.S., it is estimated
that iatrogenic causes are responsible for 225,000 deaths
each year, thus being the third leading cause of death after
heart disease and cancer [5]. Iatrogenic events have a high
incidence [10–12,19]; some studies show that 3.7% [8,9] to
17% [4,20] of all patients admitted to the hospital experience
some kind of iatrogenic event. In three major prospective
studies carried out in 1980, 1986, and 1993 in different
departments of internal medicine with 815, 1176, and 1549
patients each, the incidence found was 36% [12], 25.1%
[19], and 14.7% [10], respectively. More recent studies show
that iatrogenic events occur in 14–25% [10,19] of
hospitalized patients in internal medicine departments and
in 33% of patients over 65 years of age [18]. Almost one-
third of the patients have iatrogenic disease before hospital
admission [20] and 3–7% of all admissions have iatrogenic
causes [10,15,16,21,22], increasing to almost 8% in patients
over 65 years of age [11]. Iatrogenic events are also an
important cause of admission to intensive care units (ICUs)
[23–27] and of hospital readmission [28,29]. Little epide-
miological data is available [6,10]. However, the few studies
that are available have shown that there are some important
predictors for the occurrence of iatrogenic events, namely,
older age [10,11,14,18–21], longer hospital stay [5,10,
15,18–21], number of drugs taken daily [11,15,18,21,32],
associated pathologies [21], poor general medical status on
admission [19], associated renal function impairment or
failure [18], and IV catheterization [19]. Amongst the many
types of iatrogenic diseases, themost common seem to be drug-
related [6,9,10,12,16,21,23,30–33] or adverse drug reactions
(ADRs). ADRs are frequent, costly and, in some cases,
responsible for severe complications [6]. Generally, the patients
do not know the reasons, details, or side effects of their medical
treatment [21]. Depending on the series, the drugs most often
referred to are anti-hypertensive drugs (mainly diuretics),
cardiovascular drugs (mainly digoxin and digitalics; up to
15%), NSAIDs (up to 12%), hypoglycemic agents (6–12%),
anti-coagulants (10–11%), antibiotics (Abs; approximately
7%), and neuropsychiatric drugs [10,11,14,19,21,23]. Themost frequent alterations found are serum electrolyte dis-
turbances (including dehydration), metabolic/endocrine dis-
orders, gastrointestinal and liver disorders, cardiovascular
disorders, neuropsychiatric events, hematological disorders,
and infectious and hemorrhagic complications [10,11,15,17–
21]. According to the definition of type A or B (Table 1), in
order to be avoidable, an ADR must be predictable. Older
patients tend to suffer more type A reactions, whereas type B
reactions seem to occur more often in younger patients [2,23].
In the published studies, some 16–50% of all ADRs are serious
[12,14,18–20,30] and 22–80% avoidable/preventable
[6,9,10,16,20–22]. Some authors suggest strategies to fight
this “pandemic”, including enhanced educational programs
from the pre-graduate to post-graduate level, aimed at
prescribing physicians, patients, the general public, the
pharmaceutical industry, health authorities, epidemiologists,
and medical educators; measures of risk reduction (e.g.,
decreasing hospital stay, number of drugs, and technical
procedures); the setting up of databases or electronic systems
to diminish errors andADRs; and determined efforts to improve
ambulatory care [6,12–14,16,17,19,20,23,34].
There are several definitions of iatrogenic disease (or
iatrogenic illness, pathology, effect, reaction, or event).
The authors have chosen one that is broad enough to
include nosocomial infection, a major cause of mortality
and morbidity amongst the inpatient population [35] and
even after discharge [3]. The incidence of nosocomial
infection in hospitalized patients in internal medicine
wards can be as high as 2.6% [35,36], the most frequent
infections observed being urinary tract infections (UTIs),
pneumonias, Clostridium difficille-associated diarrhea,
wound infections, and sepsis [8,19,35–37]. These infec-
tious complications are usually associated with old age,
longer hospital stay, poor general medical status on
admission, IV catheterization, mechanical ventilation,
urinary catheterization, and female sex [19,35]. Thus,
iatrogenic disease is defined as any medical, therapeutic,
diagnostic, or prophylactic action that, unintentionally,
causes symptoms that need treatment, call for hospital
admission, increase hospital stay, cause permanent inca-
pacity or injury, or lead to death. Overall, departments of
Table 2
Iatrogenic events before and after admission and related mortality
Iatrogenic disease episodes (121) N %
Patients admitted for iatrogenic disease 44 36.36
Lead to patients' death 5 11.36
Due to iatrogenic disease 3 6.82
Events occurring in the ward (58 inpatients) 77 63.64
Lead to patients' death 9 15.51
Due to iatrogenic disease (nosocomial infections) 4 6.89
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problem [16].
The aim of this prospective study was to identify,
quantify, and characterize episodes and types of iatrogenic
disease occurring in hospitalized patients in a department of
internal medicine (Medicina 2-HUC) over a 12-month period
(from March 1, 2003 to March 1, 2004). We also sought to
shed light on risk factors for the occurrence of iatrogenic
disease in our inpatients and, thus, suggest the necessary
strategies to prevent or avoid them.
2. Materials and methods
This was a prospective study done by inviting all
inpatients in the department to systematically complete aTable 3
General characteristics of the study population and comparison of the two groups
Study population Iatrogenic disease Chi-square
Data analyzed With Without χ2; df P v
Gender ♀ 46 (45.1%) 186 (54.22%) 2.626;1 0.1
♂ 56 (54.9%) 157 (45.78%)
Age Years a
(mean±SD)
77.56±12.8 70.77±18.28 5.609;1 0.0
Educational level Illiterate 36 86
Literate; 58 211 4.128;1 0.0
Higher
education
8 46
Origin Home 64 271
Nursing
home
23 37 11.65;1 0.0
Hospital 15 34
Admission Urgent 92 289
Elective 10 54 2.447;1 0.1
None 59 208
Previous hospital
stay
N1 in the last
12 months
43 135 0.313;1 0.6
Hospital stay Days b
(mean±SD)
13.52±8.465 9.09±5.797 5.727;1 0.0
Associated
chronic condition
None 9 76 9.362;1 0.0
Yes 93 267
♀: female sex; ♂: male sex; χ2; df: chi-square difference; P value summary: ⁎
statistically significant in two-tailed test with alpha b0.05; Y: yes; N: no; RR: rela
a Risk calculated for ages N70 years; t student test applied to mean age: pb0.0
b Risk calculated for hospital stay N4 days; t student test applied to mean hosp2-page questionnaire, showing electronic prescriptions, over
the course of 1 year. Permission was obtained from the
ethics committee. Every questionnaire answered was later
reviewed. For every incomplete questionnaire, discharge
reports and clinical files were reviewed, allowing missing
data to be completed. Data underwent statistical analysis and
results were reported.
The study was carried out by seven physicians in the
department, four of whom were responsible in the ward (two
created the database and carried out the statistical analysis)
and three senior advisers. The responsible physicians filled
out the questionnaires and the senior physicians indepen-
dently reviewed them; they then decided by consensus which
cases were due to iatrogenic episodes. For those suffering
from iatrogenic disease, the disease was described and
classified by severity and type. The senior physicians then
further classified the iatrogenic events by predictability,
avoidability, and type.
Patients undergoing cytostatic (QT), immunosuppressive
(IS), or radiation therapy (RT) were excluded, as were
patients who stayed less than 2 days (short hospital stay),
those with no electronic drug prescriptions, and “social
cases”. The latter refers to patients who stay in the hospital
after clinical discharge for several reasons (e.g., lack of
cooperation from next-of-kin, no fixed residence, abandon-
ment by family, loss of vacancy in nursing home, etc.) TheseStrength of association
alue P value
summary
Significant RR 95% CI OR 95% CI
05 ns N 0.7542 0.535–1.063 0.6934 0.4447–1.081
179 ⁎ Y 1.875 1.075–3.269 2.171 1.129–4.174
422 ⁎ Y 1.444 1.019–2.047 1.63 1.015–2.618
006 ⁎⁎⁎ Y 1.83 1.305–2.567 2.275 1.409–3.672
177 ns N 1.574 0.8659–2.86 1.757 0.8606–3.587
45 ns N 1.104 0.782–1.557 1.137 0.7255–1.781
167 ⁎ Y 1.986 1.084–3.639 2.317 1.146–4.685
022 ⁎⁎ Y 2.475 1.302–4.707 2.991 1.442–6.206
minimum to ⁎⁎⁎ maximum significance; n.s.: not significant; significant:
tive risk; OR: odds ratio; CI: confidence interval; SD: standard deviation.
001.
ital stay: pb0.0001.
Table 4
Comparison of the two groups at admission
At admission Iatrogenic
disease
Chi-square Strength of association
Data analyzed With Without χ2; df P value P value
summary
Significant RR 95% CI OR 95% CI
Prognosis Mild 20 168
Moderate 47 118 26.61;1 b0.0001 ⁎⁎⁎ Y 2.999 1.91–4.71 3.936 2.31–6.706
Severe 35 57
Global clinical
impression
Good 15 145
Average 35 109 22.76;1 b0.0001 ⁎⁎⁎ Y 2.242 1.607–3.128 2.968 1.879–4.689
Bad 52 89
Functional
status
Not dependent 47 97 11.80;1 0.0006 ⁎⁎⁎ Y 1.805 1.291–2.522 2.199 1.395–3.466
Dependent 55 246
Level of
awareness
Aware 40 206
Confused 45 105 4.379;1 0.0377 ⁎ Y 1.616 1.054–2.48 1.944 1.030–3.669
Coma 17 32
Associated renal
failure/
No 33 222 33.67;1 b0.0001 ⁎⁎⁎ Y 2.806 1.938–4.062 3.836 2.397–6.14
impaired renal
function
Yes 69 121
Associated hepatic
failure/
No 57 234 7.062;1 0.0079 ⁎⁎ Y 1.583 1.13–2.218 1.835 1.169–2.88
impaired liver
function
Yes 45 109
Drugs Nr. a
(mean±SD)
5.42±
2.375
3.472±
2.44
20.59; 1 b0.0001 ⁎⁎⁎ Y 10.15 2.554–40.37 13.38 3.216–55.63
Which? ABs 5 14 1.799;1 0.1799 ns N 1.376 0.877–2.158 1.539 0.8166–2.899
ACEIs 9 14 4.930;1 0.0264 ⁎ Y 1.484 1.052–2.092 1.689 1.06–2.69
Anti-platelet/
anti-coagulants
3 1 4.656;1 0.0309 ⁎ Y 1047 1.041–2.067 1.669 1.045–2.665
Diuretics 12 19 6.044;1 0.014 ⁎ Y 1.528 1.089–2.144 1.744 1.116–2.725
Digitalics/
digoxin
2 8 3.958;1 0.0466 ⁎ Y 1.508 1.021–2.228 1.747 1.004–3.041
Insulin 4 9 6.698;1 0.0097 ⁎⁎ Y 1.768 1.18–2.65 2.225 1.20–4.125
Anti-depressants/
neuroleptics
3 21 0.9785;1 0.3226 ns N 1.193 0.8425–1.69 1.26 0.796–1.993
Steroids 2 9 0.1376;1 0.7107 ns N 1.147 0.563–2.333 1.199 0.4597–3.125
NSAIDs 7 22 0.6946;1 0.4046 ns N 1.209 0.78–1.873 1.286 0.711–2.325
χ2; df: chi-square difference; P value summary: ⁎ minimum to ⁎⁎⁎ maximum significance; n.s.: not significant; significant: statistically significant in two-tailed
test with alpha b0.05; Y: yes; N: no; RR: relative risk; OR: odds ratio; CI: confidence interval; SD: standard deviation; Nr: number; AB's: antibiotics; ACEI's:
ACE inhibitors; NSAID's: non-steroid anti-inflammatory drugs.
a Risk calculated for Nr of drugs on admission ≥2; t student test applied to mean Nr of drugs on admission: pb0.0001.
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study until they were clinically ready for discharge; the
remaining stay was excluded. Questionnaires with missing
data that were impossible to complete, even after a review of
clinical files (discharge reports and electronics chart), were
also excluded.
The database was created in Excel and the statistical analy-
sis was done using Prism4. Theχ2 test was used for categorical
variables (contingency tables) and Student's t-test for non-
parametrical variables. All P values, relative risk (RR)
and odds ratio (OR) results were obtained with two-tailed
tests for an alpha below 5% and a confidence interval
of 95%. The results are presented as a comparison of the
two groups (those with iatrogenic illness versus those
without).2.1. Questionnaire
The information requested on the questionnaire included:
Identification: Name; sex; age; occupation; degree of educa-
tion (higher education; literate; illiterate)
Origin: Hospital; home; nursing home
Type of admission: Elective; urgent; date of admission; date
of discharge; previous hospitalizations in the last
12 months
Diagnosis (or hypothesis) and prognosis: Diagnosis on
admission; diagnosis at discharge; prognosis (mild:
no life expectancy reduction by sex and age group;
moderate: life expectancy N3 years; severe: life
expectancy b3 years)
Table 5
Comparison of the two groups during in-hospital stay
During hospital stay Iatrogenic disease Chi-square Strength of association
Data analyzed With Without χ2; df P value P value summary Significant RR 95% CI OR 95% CI
Drugs Nr. a (mean±SD) 7.373±
2.261
5.438±
2.323
41.4; 1 b0.0001 ⁎⁎⁎ Y 3.08 2.139–4.437 4.415 2.756–7.074
Which? AB's 21 48 0.0842;1 0.7717 ns N 0.9439 0.6401–1.392 0.9253 0.5477–1.563
ACEI's 9 20 1.271;1 0.2595 ns N 1.221 0.8647–1.724 1.298 0.8241–2.045
Anti-platelet/
anti-coagulants
1 2 7.224;1 0.0072 ⁎⁎ Y 1.661 1.134–2.433 1.91 1.186–3.075
Diuretics 20 28 0.03819;1 0.8451 ns N 0.9623 0.655–1.413 0.9455 0.539–1.659
Digitalics/
digoxin
3 12 1.332;1 0.2485 ns N 1.266 0.8546–1.876 1.368 0.8025–2.33
Insulin 10 14 3.391;1 0.0656 ns N 1.414 0.9856–2.028 1.587 0.9682–2.602
Anti-depressants/
neuroleptics
5 13 1.041;1 0.3076 ns N 1.21 0.8421–1.74 1.285 0.7931–2.082
Steroids 9 13 0.04108;1 0.8394 ns N 1.05 0.6585–1.673 1.065 0.5782–1.963
NSAID's 1 6 0.3271;1 0.5674 ns N 0.8394 0.4549–1.549 0.8003 0.3725–1.719
χ2; df: chi-square difference; P value summary: ⁎ minimum to ⁎⁎⁎ maximum significance; n.s.: not significant; significant: statistically significant in two-tailed
test with alpha b0.05; Y: yes; N: no; RR: relative risk; OR: odds ratio; CI: confidence interval; SD: standard deviation; Nr: number; AB's: antibiotics; ACEI's:
ACE inhibitors; NSAID's: non-steroid anti-inflammatory drugs.
a Risk calculated for Nr of drugs during hospital stay ≥3; t student test applied to mean Nr of drugs during hospital stay: pb0.0001.
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pression (good, average; bad; dependent); level of
awareness (A) coma; confused; conscious/aware);
associated renal failure/impaired renal function (A);
hepatic failure/impaired liver function (A); associ-
ated chronic illness (which?);
Clinical condition at discharge (d): Outcome (D) (better;
same condition; worse; death; transferred for
iatrogenic illness); level of awareness (D) (coma;
confused; conscious/aware); hepatic failure/im-
paired liver function (D) (encephalopathy; ascites;
jaundice; albumin; INR; prothrombin time); renal
failure/impaired renal function (D) (creatinine;
BUN)
Drug-taking history: Drugs on admission (previous 4weeks);
patient's knowledge about: i) the disease; ii) the
medication; iii) the side effects; drugs during hospital
stay; drugs at discharge
Iatrogenic illness: Yes, no; description; severity (mild: no
need for specific treatment; moderate: caused or
increased hospital stay or needed specific treatment;
severe: caused incapacity or death); type (drug-
related; other)
Review by senior physicians
Iatrogenic disease: Yes; no: predictable; avoidable; drug-
related (inadequate doses; inappropriate indication;
incorrect administration; drug interaction; side
effects or adverse reactions); other (technical pro-
cedure; falls; diagnostic errors; pressure ulcers;
dietetic errors)
After the first 2 months, preliminary results were
presented to all of the physicians in the department and aset of objectives was established. The major events and those
most often observed were reviewed. Since ours is a
university hospital, trainees are included in the wards and
perform some simple techniques (it was assumed they
also play a role in iatrogenic events). Certain rules were
implemented during the ongoing study in order to try to
reduce some events, such as hematomas post-arterial
catheterization by local compression for no less than
3 min, patient-to-patient contamination by judicious hand
washing after every contact, efforts to reduce the number of
drugs taken daily by the patients, and special attention to
older patients.
3. Results
3.1. Study population
From March 1, 2003 to March 1, 2004, 879 patients were
admitted to our department. One hundred sixty-four of these
patients died, accounting for an 18.65% mortality rate. A
total of 457 questionnaires (52%) were answered, though
only 266 (58.2%) were complete; the rest needed to be
completed by reviewing discharge reports and clinical files
(electronics chart). The questionnaires of 12 patients (2.63%)
were excluded: 7 of whom were undergoing QT or RT, 1
“social case” (this patient had been discharged before the
beginning of the study and was staying in the hospital for
social reasons since there was a lack of cooperation from
the family, who refused to take him home), and 4 with an
insufficiently answered questionnaire (even after review
of the clinical file, by accessing discharge reports and
electronics charts, it was not possible to complete the
missing data in these cases). A total of 445 patient
questionnaires were ultimately included in the analysis.
Table 6
Comparison of the two groups at discharge
At discharge Iatrogenic
disease
Chi-square Strength of association
Data analyzed With Without χ2; df P value P value
summary
Significant RR 95% CI OR 95% CI
Global clinical
impression
Good 29 172 7.084;1 0.0078 ⁎⁎ Y 1.894 1.223–2.934 2.444 1.245–4.798
Average 43 112
Bad 16 26
Functional status Not
dependent
20 54 2.654;1 0.1033 ns N 1.404 0.9413–2.096 1.563 0.9108–2.680
Dependent 67 258
Level of awareness Aware 50 237 11.06;1 0.0009 ⁎⁎⁎ Y 1.873 1.3–2.698 2.298 1.397–3.779
Confused 37 72
Coma 0 3
Associated renal
failure/
No 73 280 6.622;1 0.0101 ⁎ Y 1.668 1.141–2.44 1.976 1.169–3.339
impaired renal
function
Yes 29 63
Associated hepatic
failure/
impaired liver
function
No 62 239 1.184;1 0.2766 ns N 1.255 0.838–1.881 1.344 0.788–2.293
Yes 25 72
Drugs Nr. a
(mean±SD)
4.909±
1.74
4.236±
2.249
12.79;1 0.0003 ⁎⁎⁎ Y 2.281 1.403–3.710 2.792 1.566–4.977
Patient's knowledge
about
Disease 39 186 8.806;1 0.003 ⁎⁎ Y 0.5918 0.4156–0.8427 0.5071 0.3225–0.7974
Medication 30 147 5.933;1 0.0149 ⁎ Y 0.6309 0.4309–0.9238 0.5556 0.3449–0.8949
Side effects 11 85 9.104;1 0.0026 ⁎⁎ Y 0.4394 0.2452–0.7877 0.3669 0.1874–0.7185
Outcome Better 66 231 4.041;1 0.0444 ⁎ Y 1.525 1.027–2.263 1.776 1.009–3.124
Same
condition
15 64
Worse 6 15
Death 15 31
Mortality rate 14.71% 9.04% 2.725.1 0.0988 ns N 1.496 0.9486–2.358 1.735 0.8961–3.36
χ2; df: chi-square difference; P value summary: ⁎ minimum to ⁎⁎⁎ maximum significance; n.s.: not significant; significant: statistically significant in two-tailed
test with alpha b0.05; Y: yes; N: no; RR: relative risk; OR: odds ratio; CI: confidence interval; SD: standard deviation; Nr: number.
a Risk calculated for Nr of drugs at discharge ≥4; t student test applied to mean Nr of drugs at discharge: p=0.0054.
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102 inpatients registered 121 episodes of iatrogenic disease,
yielding a 22.9% incidence. In 343 inpatients, there was no
iatrogenic illness. Of all the patients suffering episodes of
iatrogenic disease, 44 (43.13%) were admitted for iatrogenic
events; 5 of them (11.36%) died, 3 (6.82%) from the ad-
mission cause, so iatrogenic disease was considered to be theFig. 1. Incidence and main caucause of death. In 58 inpatients, 77 episodes (63.63%) of
iatrogenic disease were registered in the ward, 4 of which
(6.89%) also lead to the patient's death, all due to nos-
ocomial infections (Table 2). A total of 9 (15.51%) out of 58
inpatients died during their hospital stay; iatrogenic events
were thus fatal in nine cases. Iatrogenic events were fatal in
seven cases, accounting for a mortality rate of 1.6% of allses of iatrogenic disease.
Fig. 2. Types of ADR's.
Fig. 4. Severity of iatrogenic disease.
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iatrogenic events.
The two groups were similar in male/female ratio. The
group suffering from iatrogenic disease was, on average,
6.79 years older than the disease-free group, and over the age
of 70, the risk of iatrogenic events increased significantly. The
mean age in the first group was 77.56±12.8 (range 14–101)
years and in the second group 70.77±18.28 (range 29–98)
years. Patients with a lower educational level, those with any
associated chronic disease, and those coming from other
hospitals or a nursing home were more affected by iatrogenic
events (Table 3). No differences were found in either group in
the type of admission (urgent or elective) or admissions in the
previous year (b or N6 months). The patients suffering from
iatrogenic disease had a significantly longer hospital stay —
on average, 4.43 days longer- and a stay longer than 4 days is
significant in the increase of risk for iatrogenic events. The
mean hospital stay was 13.52±8.46 (range 1–32) days in the
first group and 9.09±5.79 (range 1–28) days in the second
group (Table 3).
Prognosis, patients' general functional status, and levels
of awareness on admission were worse in the group with
iatrogenic illness. Although the criterion is subjective and
variable depending on the physician, the patients' global
clinical impression was consistent with the other criteria and
was also worse in the same group. Iatrogenic illness was
more frequent in patients suffering from impaired renalFig. 3. Types of iatrogenic disease due to technical causes.function or renal failure on admission and in patients
suffering from impaired hepatic function or liver failure on
admission. On admission and in the previous 4 weeks, the
group with iatrogenic events took more drugs daily— 1.498
more — than the other group, and the patients taking 2 or
more drugs showed a higher risk of iatrogenic events
(Table 4). Diuretics, ACEIs, anti-coagulant/anti-platelet
drugs, digitalics/digoxin, and insulin were significantly
more frequent on admission in the patients who suffered
from iatrogenic events (Table 4).
During hospitalization the occurrence of iatrogenic events
was also found to be related to the number of drugs taken
daily. The group with iatrogenic events was taking 1.93 more
drugs than the other group, with the patients taking three or
more drugs at the greatest risk (Table 5). Anti-coagulants/
anti-platelet drugs were more frequently prescribed to these
patients during hospitalization (Table 5).
Both groups showed the same general functional status at
discharge. Patients with a worse global clinical impression
and patients with a lower level of awareness at discharge
suffered more events of an iatrogenic illness. At discharge
from the department, the group with iatrogenic illness was
the one to show a higher incidence of impaired renal function
or renal failure, yet, no significant differences were found
between the two groups with relation to impaired hepatic
function or liver failure at discharge. At discharge the
number of iatrogenic events also proved to be related to the
number of drugs prescribed, the group with iatrogenic illness
taking 0.734 more drugs daily than the other group and the
risk increasing for patients taking four or more drugs. The
patients' knowledge about the disease, the medication, and
the side effects was significantly lower in the group with
iatrogenic illness, and this group also showed a worse
clinical outcome. Both groups had a similar mortality rate
(Table 6).
The incidence of iatrogenic illness was 22.9% in the
series studied. Most iatrogenic events in this series were
drug-related, followed by those resulting from technical
procedures (Fig. 1). Some 60% of drug-related iatrogenic
illnesses were due to side effects or ADRs, 20% to
inappropriate doses, and 10% to drug interactions (Fig. 2).
The technical causes of iatrogenic events were mainly
Fig. 5. Predictable and avoidable iatrogenic disease.
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followed by surgery and pressure ulcers (Fig. 3).
Infections were the most frequent disorders observed in
this series (24%), followed by electrolyte (18%), metabolic/
endocrine (12%), gastrointestinal (8%), hematological/coag-
ulation disorders (9%), neurological (4%), cardiovascular
(2.5%) and skin/allergic manifestations (2%). There are
records of nine respiratory infections, six urinary infections,
two nosocomial conjunctivitis, one head trauma after a fall
from bed, and one post-liver biopsy hematoma (patient did
not abide to the physician's recommendation to stay in bed).
Of the confirmed events of iatrogenic illness, about 18%
were classified as severe and 24% as moderate (Fig. 4),
causing death in 2.02% of the study population (8.82% in the
group with iatrogenic illness).
As in series in several other studies, iatrogenic events
proved to be 61.9% predictable and 54.55% avoidable (Fig. 5).
The risk factors identified by this study are: age over
70 years, lower educational level, transfer from other
institutions, hospital stay longer than 4 days, associated
chronic condition, severe prognosis on admission, global
clinical impression on admission and at discharge, general
functional status on admission, level of awareness on
admission and at discharge, associated renal failure or
impaired renal function on admission and at discharge,
associated hepatic failure or impaired liver function on
admission, number of drugs taken (2 or more drugs on
admission, 3 or more drugs during hospital stay, 4 or more
drugs at discharge), and the patients' knowledge about the
disease, the medication, and its side effects. Iatrogenic disease
can also be considered a risk factor for a worse outcome.
4. Discussion
The most difficult task to accomplish in the present study
was to obtain the cooperation of all practitioners with regard
to filling out the questionnaires, even though there was one
responsible physician for each sector in the ward. In fact,
during the summer months (from June to September) and in
December, a much smaller number of questionnaires were
filled out compared to during other periods of the year, these
being the most common holiday periods.Although the preliminary results (obtained after the first
2 months and presented to all physicians in the department)
were not considered in this study, the overall comparison of
the 2-month and 12-month results shows a slight reduction in
iatrogenic events. The number of events may have been
reduced after implementation of the simple rule that a review
of the major events and those most often observed lead to.
Reading the results can create a false idea that the
population studied has a lower mortality rate than the total
population of inpatients (total of admissions); this is not
accurate. Such results occur most probably because some
patients died within the first 24 h after admission; thus, the
questionnaires were not completed, regardless of the cause of
death. In fact, in all completed questionnaires, less than 10%
correspond to patients who died, but the real mortality rate is
almost twice as high.
The incidence of iatrogenic events is high in the population
studied as it includes nosocomial infection. Still, it may be
underestimated, as only about half of the patients admitted
were analyzed (only 51.88% completed questionnaires).
Overall, the results found are very similar to those found
in the published medical literature in terms of incidence, risk
factors, severity, avoidability, and type of iatrogenic disease.
The size of our study population was large enough for us to
draw conclusions and to identify risk factors for iatrogenic
events, and that is precisely what we did.
It is very important to increase patients' knowledge about
their diseases and their medication and to inform them about
possible side effects and ADRs as a way of reducing
iatrogenic events. It also seems fair to conclude that all
iatrogenic events should be reviewed and used for compre-
hensive management, as was attempted by presenting the
preliminary results. Through a common strategy, established
objectives, and teamwork, it is possible to forecast and to
change attitudes and behavior to “avoid the avoidable”.
Electronic prescription may be helpful for physicians as it
can help reduce errors, provide information on drug safety,
calculate doses, and alert them to possible drug interactions.
Finally, and as redundant as it may seem, we have once
again shown that elderly patients with chronic disease and
polypharmacy are the preferential “targets” of iatrogenic
illness. They should receive increased attention from all
health care workers.
5. Learning points
• Iatrogenic events have a high incidence in internal
medicine wards. They are mainly drug-related (ADRs),
due to nosocomial infections or to technical, diagnostic,
and therapeutic procedures.
• As expected, older patients, patients with a longer
hospital stay, those who take several drugs daily, and
those who exhibit serious conditions (that can worsen the
prognosis) have a much higher incidence of iatrogenic
disease. The physician's judgement of the patient's
clinical impression is an important risk predictor.
399S. Madeira et al. / European Journal of Internal Medicine 18 (2007) 391–399• Iatrogenic events may worsen the patients' outcome, as an
isolated risk factor.
• It is possible to avoid many of the diseases we cause since
most of them are predictable and avoidable. It is important
to pay special attention to high-risk groups.
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